ACA
BIIB icon

Anchor Capital Advisors’s Biogen BIIB Stock Holding History

Anchor Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-46,459
Closed -$11K – 245
2019
Q1 		$11K Buy
46,459
+1,539
+3% +$485K 0.23% 91
2018
Q4 		$13.5M Sell
44,920
-1,101
-2% -$351K 0.55% 85
2018
Q3 		$16.3M Buy
+46,021
New +$15.8M 0.59% 76
2018
Q2 		– Sell
-6,000
Closed -$1.64M – 282
2018
Q1 		$1.64M Buy
+6,000
New +$1.86M 0.06% 135

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Anchor Capital Advisors's BIIB Position: Q2 2019 in Review

Anchor Capital Advisors sold out of Biogen (BIIB) in Q2 2019, closing a stake of 46,459 shares — an estimated $11K sold.

Anchor Capital Advisors first reported a position in BIIB in Q1 2018 and held it in 4 quarters. The position peaked at $16.3M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Anchor Capital Advisors reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Anchor Capital Advisors sold 46,459 Biogen shares in Q2 2019, an estimated $11K.
  • Anchor Capital Advisors first reported a position in Biogen in Q1 2018 and held it in 4 quarters.
  • Anchor Capital Advisors's Biogen position peaked at $16.3M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Anchor Capital Advisors's 13F filing for Q2 2019, filed 1 Aug 2019.